Showing results (171-180 of 226) with videos related to

Sort By:
Pageof 23
JCI Insight|November 25, 2016
Plasma vesicle miRNAs for therapy response monitoring in Hodgkin lymphoma patientsMonique Aj van Eijndhoven, Josée M Zijlstra, Nils J Groenewegen, et al.
British Journal of Haematology|April 27, 2013
Comparison of modern and conventional imaging techniques in establishing multiple myeloma-related bone disease: a systematic reviewJosien C Regelink, Monique C Minnema, Evangelos Terpos, et al.
Cancer|October 25, 2022
Breast cancer and cardiovascular outcomes after breast cancer in survivors of Hodgkin lymphomaInge M Krul, Naomi B Boekel, Iris Kramer, et al.
Cancer Medicine|December 29, 2018
Overall and disease-specific survival of Hodgkin lymphoma survivors who subsequently developed gastrointestinal cancerLisanne S Rigter, Michael Schaapveld, Cecile P M Janus, et al.
Haematologica|January 8, 2026
Improving the predictive value of end-of-treatment PET/CT in diffuse large B-cell lymphomaAnne L Bes, Gerben J C Zwezerijnen, Martijn W Heymans, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 2024
International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline 18F-FDG PET/CT of Lymphoma Patients: A Milestone Toward Clinical ImplementationRonald Boellaard, Irène Buvat, Christophe Nioche, et al.
British Journal of Haematology|July 11, 2019
Rituximab-PECC induction followed by 90 Y-ibritumomab tiuxetan consolidation in relapsed or refractory DLBCL patients who are ineligible for or have failed ASCT: results from a phase II HOVON studyPieternella J Lugtenburg, Josee M Zijlstra, Jeanette K Doorduijn, et al.
Blood|March 31, 2023
Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphomaJ J Eertink, G J C Zwezerijnen, M W Heymans, et al.
British Journal of Haematology|March 10, 2020
Bortezomib maintenance after R-CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a randomised phase II HOVON trialJeanette K Doorduijn, Josee M Zijlstra, Pieternella J Lugtenburg, et al.
Med (New York, N.Y.)|May 19, 2022
In-depth cell-free DNA sequencing reveals genomic landscape of Hodgkin's lymphoma and facilitates ultrasensitive residual disease detectionSophia Sobesky, Laman Mammadova, Melita Cirillo, et al.
Pageof 23